HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Peter F. Roberts Federico Venuta Erino Rendina Giorgio F. Coloni David M. Follette John R. Benfield Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roberts, P. F. Articles by Benfield, J. R. Search for Related Content PubMed PubMed Citation Articles by Roberts, P. F. Articles by Benfield, J. R. Related Collections Mediastinum

J Thorac Cardiovasc Surg 2001;122:562-568
© 2001 The American Association for Thoracic Surgery

General Thoracic Surgery (GTS)

Thymectomy in the treatment of ocular myasthenia gravis

From the Division of Cardiothoracic Surgery^a and the Department of Neurology,^b University of California, Davis, Medical Center, Sacramento, Calif, and the Department of Thoracic Surgery,^c University of Rome, "La Sapienza," Rome, Italy.

Received for publication Oct 2, 2000. Revisions requested Jan 8, 2001; revisions received March 7, 2001. Accepted for publication April 4, 2001. Address for reprints: Peter F. Roberts, MD, Division of Cardiothoracic Surgery, University of California, Davis, Medical Center, 2221 Stockton Blvd, 2nd Floor, Sacramento, CA 95817 (E-mail: peter.roberts @ucdmc.ucdavis.edu).

Abstract

Background: Thymectomy is an effective and accepted treatment for myasthenia gravis, but thymectomy for ocular myasthenia gravis (Osserman stage I) is controversial.
Objective: To assess the efficacy and propriety of thymectomy for the treatment of ocular myasthenia gravis.
Methods: We conducted a review and follow-up of all patients who had thymectomy for the treatment of ocular myasthenia gravis between 1970 and 1998 at the University of California, Davis, Medical Center, and the University of Rome, "La Sapienza," Rome, Italy. Patient response to thymectomy was categorized as follows: cured, patients who became symptom-free and required no further medication; improved, patients who required less medication and whose symptoms were less severe; unchanged, patients whose symptoms and medications were the same; worse, patients who had more severe symptoms, needed more medication, or died.
Results: Sixty-one patients (mean age 37 years; range 14–73 years) were followed up for a mean duration of 9 years (range 0.5–29 years). Ocular myasthenia gravis with mixed and cortical thymomas, stages I to IV, occurred in 12 patients, and ocular myasthenia without thymomas occurred in 49 patients. Transsternal thymectomy (n = 55) and transcervical thymectomy (n = 6) resulted in cure in 31 (51%) patients, improvement in 12 (20%) patients, no change in 16 (26%) patients, and worsening of symptoms (including 1 postoperative death) in 2 patients. Patient outcomes were statistically independent of the duration of preoperative symptoms (mean 9.5 months), patient age, or the presence or absence of thymoma. In patients with ocular myasthenia, 70% were cured or improved after thymectomy; in the subgroup of patients with ocular myasthenia and thymoma, 67% were cured or improved.
Conclusion: Thymectomy is an effective and safe treatment for patients with ocular myasthenia gravis.

This article has been cited by other articles:

				D. M. Meyer, M. A. Herbert, N. C. Sobhani, P. Tavakolian, A. Duncan, M. Bruns, K. Korngut, J. Williams, S. L. Prince, L. Huber, et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches. Ann. Thorac. Surg., February 1, 2009; 87(2): 385 - 390. [Abstract] [Full Text] [PDF]

				M. E. Gilbert, E. A. De Sousa, and P. J. Savino Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy Arch Neurol, December 1, 2007; 64(12): 1790 - 1792. [Full Text] [PDF]

				P. S. Chavis, D. E. Stickler, and A. Walker Immunosuppressive or Surgical Treatment for Ocular Myasthenia Gravis Arch Neurol, December 1, 2007; 64(12): 1792 - 1794. [Full Text] [PDF]

				S. Endo Reply. Ann. Thorac. Surg., May 1, 2006; 81(5): 1946 - 1947. [Full Text] [PDF]

				A. C. Bragdon, D. P. Richman, and M. A. Agius Treatment of autoimmune myasthenia gravis Neurology, September 28, 2004; 63(6): 1138 - 1139. [Full Text] [PDF]

				S. Endo, T. Yamaguchi, N. Saito, S. Otani, T. Hasegawa, Y. Sato, and Y. Sohara Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis Ann. Thorac. Surg., May 1, 2004; 77(5): 1745 - 1750. [Abstract] [Full Text] [PDF]

				P. Wang, C. Zuo, J. Tian, Z. Qian, F. Ren, C. Shao, M. Wang, and T. Lu CT-Guided Percutaneous Ethanol Injection of the Thymus for Treatment of Myasthenia Gravis Am. J. Roentgenol., September 1, 2003; 181(3): 721 - 724. [Abstract] [Full Text] [PDF]

				M. Lucchi, A. Mussi, R. Ricciardi, and C. A. Angeletti Thymectomy in ocular myasthenia gravis J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 740 - 741. [Full Text] [PDF]

				J. B. Shrager, M. E. Deeb, R. Mick, C. J. Brinster, H. E. Childers, M. B. Marshall, J. C. Kucharczuk, S. L. Galetta, S. J. Bird, and L. R. Kaiser Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy Ann. Thorac. Surg., August 1, 2002; 74(2): 320 - 327. [Abstract] [Full Text] [PDF]